2-24203719-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_006277.3(ITSN2):āc.5001T>Cā(p.Pro1667=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000668 in 1,614,202 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.0036 ( 3 hom., cov: 32)
Exomes š: 0.00036 ( 3 hom. )
Consequence
ITSN2
NM_006277.3 synonymous
NM_006277.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.51
Genes affected
ITSN2 (HGNC:6184): (intersectin 2) This gene encodes a cytoplasmic protein which contains SH3 domains. This protein is a member of a family of proteins involved in clathrin-mediated endocytosis. Intersectin 2 is thought to regulate the formation of clathrin-coated vesicles and also may function in the induction of T cell antigen receptor (TCR) endocytosis. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 2-24203719-A-G is Benign according to our data. Variant chr2-24203719-A-G is described in ClinVar as [Benign]. Clinvar id is 3039372.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-1.51 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ITSN2 | NM_006277.3 | c.5001T>C | p.Pro1667= | synonymous_variant | 40/40 | ENST00000355123.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ITSN2 | ENST00000355123.9 | c.5001T>C | p.Pro1667= | synonymous_variant | 40/40 | 1 | NM_006277.3 | P2 | |
ITSN2 | ENST00000361999.7 | c.4920T>C | p.Pro1640= | synonymous_variant | 39/39 | 1 | A2 | ||
ITSN2 | ENST00000478720.1 | n.1180T>C | non_coding_transcript_exon_variant | 2/2 | 2 | ||||
ITSN2 | ENST00000427234.5 | c.*370T>C | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00365 AC: 555AN: 152218Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
555
AN:
152218
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000927 AC: 233AN: 251448Hom.: 2 AF XY: 0.000589 AC XY: 80AN XY: 135912
GnomAD3 exomes
AF:
AC:
233
AN:
251448
Hom.:
AF XY:
AC XY:
80
AN XY:
135912
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000358 AC: 524AN: 1461866Hom.: 3 Cov.: 31 AF XY: 0.000300 AC XY: 218AN XY: 727230
GnomAD4 exome
AF:
AC:
524
AN:
1461866
Hom.:
Cov.:
31
AF XY:
AC XY:
218
AN XY:
727230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00364 AC: 555AN: 152336Hom.: 3 Cov.: 32 AF XY: 0.00360 AC XY: 268AN XY: 74500
GnomAD4 genome
AF:
AC:
555
AN:
152336
Hom.:
Cov.:
32
AF XY:
AC XY:
268
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ITSN2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 26, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at